Vertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?

Insider buying vs selling

Have Vertex Pharmaceuticals Inc insiders been buying or selling?
Reshma KewalramaniCEO President2024-05-2015,202$447.00
David AltshulerEVP Chief Scientific Officer2024-05-1554$430.93
Stuart A. ArbuckleEVP COO2024-05-1569$430.93
Amit SachdevEVP Chief Patient Ext Af Off2024-05-1532$430.93
Sangeeta N. BhatiaDirector2024-05-02467$402.95
Kristen AmbroseSVP Chief Accounting Officer2024-04-02240$419.00
Kristen AmbroseSVP Chief Accounting Officer2024-04-01225$418.10
Stuart A. ArbuckleEVP COO2024-02-265,034$425.70
Ourania TatsisEVP Chief Reg. Quality Off.2024-02-26354$425.70
Kristen AmbroseSVP Chief Accounting Officer2024-02-26883$425.70

1 of 12

VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRTX insiders and whales buy or sell their stock.

VRTX Shareholders

What type of owners hold Vertex Pharmaceuticals Inc stock?
Capital World Investors9.91%25,567,184$11.30BInstitution
Vanguard Group Inc8.79%22,676,518$10.02BInstitution
Blackrock Inc8.51%21,960,687$9.71BInstitution
State Street Corp4.65%12,006,483$5.31BInstitution
Fmr LLC4.14%10,673,520$4.72BInstitution
Alliancebernstein LP2.75%7,097,281$3.14BInstitution
Jpmorgan Chase Co2.33%6,018,124$2.66BInstitution
Geode Capital Management LLC2.25%5,813,036$2.57BInstitution
Capital Research Global Investors2.23%5,743,882$2.54BInstitution
Jennison Associates LLC1.85%4,782,374$2.11BInstitution

1 of 3

VRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRTX89.70%1.49%Net SellingNet Selling
REGN69.50%30.50%Net SellingNet Selling
MRNA67.58%21.58%Net SellingNet Selling

Vertex Pharmaceuticals Stock Ownership FAQ

Who owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is owned by 89.70% institutional shareholders, 1.49% Vertex Pharmaceuticals insiders, and 8.81% retail investors. Capital World Investors is the largest individual Vertex Pharmaceuticals shareholder, owning 25.57M shares representing 9.91% of the company. Capital World Investors's Vertex Pharmaceuticals shares are currently valued at $11.44B.

If you're new to stock investing, here's how to buy Vertex Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.